PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB

Latest FY: 2025 Healthcare Medical Devices
Market Price $1.29
Market Cap $403.78M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑3.9% YoY
$160.00M
3-Yr CAGR: 7.6%
Net Income ↓-76.3% YoY
-$546.38M
Net Margin: -341.5%
Free Cash Flow ↑46.3% YoY
-$113.92M
FCF Yield: -28.21%
EPS (Diluted) ↓-14.5% YoY
$-1.82
Basic: $-1.82
Return on Equity Efficiency
-10,214.5%
ROA: -69.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (PACB)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $90.7M $44.2M $-74.4M 0.00% $-67.9M $-76.1M
FY 2017 $93.5M +3.0% $34.7M $-92.2M -24.0% 0.00% $-67.5M $-78.0M -2.4%
FY 2018 $78.6M -15.9% $25.1M $-102.6M -11.3% 0.00% $-66.4M $-68.3M +12.4%
FY 2019 $90.9M +15.6% $34.6M $-84.1M +18.0% 0.00% $-78.3M $-81.1M -18.8%
FY 2020 $78.9M -13.2% $32.6M $29.4M +134.9% $0.17 0.00% $19.5M $18.5M +122.8%
FY 2021 $130.5M +65.4% $58.9M $-181.2M -716.3% $-0.89 -623.5% 0.00% $-111.2M $-117.1M -734.3%
FY 2022 $128.3M -1.7% $49.0M $-314.2M -73.4% $-1.40 -57.3% 0.00% $-263.2M $-280.0M -139.1%
FY 2023 $200.5M +56.3% $52.8M $-306.7M +2.4% $-1.21 +13.6% 0.00% $-259.2M $-268.0M +4.3%
FY 2024 $154.0M -23.2% $37.3M $-309.9M -1.0% $-1.59 -31.4% 0.00% $-206.1M $-212.2M +20.8%
FY 2025 $160.0M +3.9% $45.8M $-546.4M -76.3% $-1.82 -14.5% 0.00% $-111.2M $-113.9M +46.3%
$

Valuation

Market Price $1.29
Market Cap $403.78M
Enterprise Value $340.08M
P/E Ratio N/A
P/B Ratio 75.20
FCF Yield -28.21%
Dividend Yield N/A
Shares Outstanding 310,601,700
%

Profitability & Margins

Gross Margin 28.61%
Operating Margin -346.15%
Net Margin -341.47%
Return on Equity (ROE) -10,214.54%
Return on Assets (ROA) -69.68%
Asset Turnover 0.20x
Revenue 3-Yr CAGR 7.64%
🛡️

Financial Health & Liquidity

Current Ratio 5.15
Cash Ratio 0.87
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $63.71M
Total Debt N/A
Book Value / Share $0.02
💧

Cash Flow Efficiency

Operating Cash Flow -$111.21M
Capital Expenditures (CapEx) $2.71M
Free Cash Flow -$113.92M
OCF / Revenue -69.50%
FCF / Revenue -71.20%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.82
EPS (Basic) $-1.82
Dividends / Share N/A
Book Value / Share $0.02
EPS YoY Growth -14.47%
🏛️

Balance Sheet (FY 2025)

Total Assets $784.08M
Total Liabilities $778.73M
Stockholders' Equity $5.35M
Current Assets $375.05M
Current Liabilities $72.83M